Qiagen has appointed Jonathan Pratt as CEO, bringing in an executive with recent experience overseeing a multibillion-dollar sale as the European molecular diagnostics company considers a potential takeover by private equity firms, according to a report by Bloomberg.
The report cites a company statement as revealing that Pratt, who most recently led Filtration Group, where he helped guide the industrial technology company through its recent $9.25bn cash sale to Parker Hannifin, will succeed Thie...
Continue Reading
Sign up for FREE to read the full article and access 154K+ alternative investment headlines.